Cassava Sciences Inc. sell stratec
Start price
27.06.18
/
50%
€1.95
Target price
02.07.18
€1.53
Performance (%)
-4.63%
End price
02.07.18
€1.86
Summary
This prediction ended on 02.07.18 with a price of €1.86. With a performance of -4.63%, the SELL prediction by stratec was trending in the right direction. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cassava Sciences Inc. | -12.894% | -12.894% | -0.164% | -93.337% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% | 68.786% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% | 100.066% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% | 43.024% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% | 63.222% |
Comments by stratec for this prediction
In the thread Cassava Sciences Inc. diskutieren
stratec stimmt dem Sentiment von 'Buy' nicht zu
stratec stimmt am 27.06.2018 dem Buy-Gesamtsentiment mit dem Kursziel 9.0$ nicht zu.
- A joint FDA panel has voted against approval for Pain Therapeutics Remoxy ER treatment.
(Vom Mitglied beendet)